https://orcid.org/0000-0002-2209-8956
References
- Ramchandran D, Upadhyay UD. Implants: The Next Generation. Population Reports. Baltimore, INFO Project, Johns Hopkins Bloomberg School of Public Health. October 2007. Available from: http://www.populationreports.org/k7/. Accessed January 28, 2021.
- Ali M, Sadler R, Cleland J, Ngo T, Shah I. Long-Term Contraceptive Protection Discontinuation and Switching Behaviour. Intrauterine Device (IUD) Use Dynamics in 14 Developing Countries. London: World Health Organization and Marie Stopes International; 2011.
- Hatcher R, Trussell J, Nelson A. Contraceptive Technology. New York, NY: Ardent Media; 2007.
- Astbury Ward E. Provision of contraception and its influence on abortion. Nurs Pract. 2009;2009:47.
- Staveteig S, Mallick L, Winter R. Uptake and Discontinuation of Long-Acting Reversible Contraceptives (Larcs) in Low-Income Countries. DHS Analytical Studies No. 54. Rockville, Maryland, USA. 2015. Available from: https://www.dhsprogram.com/publications/publication-as54-analytical-studies.cfm. Accessed January 28, 2021.
- Frost JJ, Singh S, Finer LB. U.S. women’s one-year contraceptive use patterns,2004. Perspect Sex Reprod Health. 2007;38–55.
- Kidane A, Asefa T, Asres T, et al. Assessment of Implant and IUCD Removal in Ethiopia International Conference on Family Planning Research and Best Practices Kampala, Uganda November 2009. Family Health International. 2009.
- Melkamu Y, Betre M, Tesfaye S. Utilization of post-abortion care services in three regional states of Ethiopia. Ethiop J Health Dev. 2010;2010(24 Special Issues 1):123–129.
- Central Statistical Agency (CSA) [Ethiopia] and ICF. Ethiopia Demographic and Health Survey 2016. 2016.
- Robinson, Register, Ebner, and Orr, Reducing Early Discontinuation Rates of Subdermal Contraception in Your Clinical Practice. In: Osteopathic Family Physician. Vol. 1. Addis Ababa, Ethiopia, and Rockville, Maryland, USA:CSA and ICF;2015:24–28
- Bekele T, Gebremariam A, Tura P. Factors associated with contraceptive discontinuation in Agarfa District, Bale Zone, Southeast Ethiopia. Epidemiology (Sunnyvale). 2015;5(2):179. doi:10.4172/2161-1165.1000189
- Bradley S, Schwandt HM, Khan S. Levels Trends and Reasons for Contraceptive Discontinuation. Calverton, Maryland, USA: ICF Macro. 2008.
- Balogun O, Olaomo N, Adeniran A, Fawole A. Implanon sub-dermal implant: an emerging method of contraception in Ilorin, Nigeria. J Med Biomed Sci. 2014;3(1):1–5. doi:10.4314/jmbs.v3i1.1
- Mastor A, Khaing SL, Omar SZ. Users’ perspectives on Implanon in Malaysia, a multicultural Asian country. Open Access J Contracept. 2011;Volume 2:79–84. doi:10.2147/OAJC.S9674
- Said MA-RM, Cairo U. Implanon Use Pattern Among Ministry of Health and Population Clients 2008–2012. Cairo: Faculty of Medicine; 2012.
- Peipert Jeffrey F, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117(5):1105–1113. doi:10.1097/AOG.0b013e31821188ad
- Siyoum M, Mulaw Z, Abuhay M, Kebebe H Implanon discontinuation rate and associated factors among women who ever used implanon in the last three years in Debre Markos Town, Northwest Ethiopia, 2016, cross sectional study. ARC J Public Health Community Med. 2017;2(1):8–16.
- Lori M, Vanessa A, Jessica J, et al. Satisfaction, early removal, and side effects associated with long-acting reversible contraception. Fam Med. 2013;45(10):701–707.
- Obijuru L, Bumpus S, Auinger P, et al. Etonogestrel implants in adolescents: experience, satisfaction, and continuation. J Adolesc Health. 2016;58(3):284. doi:10.1016/j.jadohealth.2015.10.254
- Harel Z, Frank M, Kollar L, et al. Adolescents’ reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. J Adolesc Health. 1996;19(2):118. doi:10.1016/1054-139X(95)00322-J
- Lara-Torre E, Spotswood L, Correia N, et al. Intrauterine contraception in adolescents and young women: a descriptive study of use, side effects, and compliance. J Pediatr Adolesc Gynecol. 2011;24:39.